全部分类
  • ATX inhibitor 5
ATX inhibitor 5的可视化放大

ATX inhibitor 5

ATX inhibitor 5 是有效的口服活性 autotaxin (ATX) 抑制剂,IC50 为 15.3 nM。AATX inhibitor 5 具有抗肝纤维化作用,并显着降低 CCl4 诱导的肝纤维化水平。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

ATX inhibitor 5的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥3775.00
    3020.00
    - +
  • 10mg
    ¥6262.00
    5010.00
    - +
  • 25mg
    ¥11875.00
    9500.00
    - +
  • 50mg
    ¥18162.00
    14530.00
    - +
  • 100mg
    ¥26712.00
    21370.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx33654
  • CAS: 2402772-45-4
  • 别名:
  • 分子式: C22H18ClF3N6O
  • 分子量: 474.87
  • 纯度: >98%
  • 溶解度: DMSO : 250 mg/mL (526.46 mM; Need ultrasonic)
  • 储存: Store at -20°C
  • 库存: 现货

Background

ATX inhibitor 5 is a potent and orally active autotaxin (ATX) inhibitor, with an IC50 of 15.3 nM. ATX inhibitor 5 shows anti-hepatofibrosis effects and reduces CCl4-induced hepatic fibrosis level prominently[1].


ATX inhibitor 5 (compound 10g) (IC50s=1.21 and 0.78 μM) displays activities against cardiac fibroblasts (CFs) and hepatic stellate cell (HSC)[1].ATX inhibitor 5 at 10 μM successfully suppresses collagen content induced by TGF-β[1].


ATX inhibitor 5 (20-40 mg/kg; p.o.; once daily for two weeks) reduces CCl4-induced hepatic fibrosis level prominently[1].


[1]. Jiang N, et al.Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis.Eur J Med Chem. 2020 Feb 1;187:111904.

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算